New drug TAX2 targets Hard-to-Treat cancers in first human trial
Disease control
Not yet recruiting
This study tests an experimental drug, TAX2, in adults with advanced or metastatic solid tumors that have not responded to standard treatments. The trial has two parts: first, finding a safe dose, and then testing that dose in more people. Researchers will monitor side effects, h…
Phase: PHASE1, PHASE2 • Sponsor: Apmonia Therapeutics • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC